Stock info Ligand Pharmaceuticals Inc | Filter  Basic-Info

Stock: Ligand Pharmaceuticals Inc (US broad)

Last Price 118.22 Max Price 129.90
Min Price 78.90 1 Year return 0.00
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USAWebsite: www.ligand.com

Sector Review Ligand Pharmaceuticals Inc

Loading...
Year Turnover Total sector Market share
2019 107 135,969 0.08 %
2020 152 152,939 0.10 %
2021 243 227,396 0.11 %
2022 183 260,129 0.07 %
2023 118 214,794 0.05 %

Advice Ligand Pharmaceuticals Inc

No Records Found




News Ligand Pharmaceuticals Inc

No Records Found

Annual reports Ligand Pharmaceuticals Inc

No Records Found


Profile Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc


The past year was a good investment year for Ligand Pharmaceuticals Inc investors

Over the last 12 months, that were loss-making period for the investors in Ligand Pharmaceuticals Inc, the stock lost around 1 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 834 percent. Ligand Pharmaceuticals Inc's revenues between 2011 and 2015 were very volatile through the time and moved between 31,39 million dollars and 71,91 million dollars. Ligand Pharmaceuticals Inc's net results between 2011 and 2015 were very fluctuating and moved between 9,71 million dollars and 254,93 million dollars.

The company mostly operates in the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.

Over the past 5 years the American company paid out dividends. In the period 2011 till 2015 Ligand Pharmaceuticals Inc paid it's investors each year a higher dividend per share. Based on the raising dividend payments Ligand Pharmaceuticals Inc can be seen as a kind of dividend aristocrat.

Ligand Pharmaceuticals Inc' balance mostly financed with equity

At the end of 2015 the pharmaceutical company's balance sheet was worth 533,93 million dollars. Of the total balance sheet 229,54 million dollars (42,99 percent) was financed by debt. As per the end of 2015 Ligand Pharmaceuticals Inc's price/earnings-ratio equaled 4. So investors paid for 1 stock 4 times the earnings per share of 2015. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 2,1 billion dollars. At the end of 2015 the American company had around 19,79 million stocks listed on the exchanges.

All Ligand Pharmaceuticals Inc's annual reports can be found here. More information about Ligand Pharmaceuticals Inc can be found it's website. .


Results Ligand Pharmaceuticals Inc

Results
2015
2016
2017
2018
2019
2020
Revenue
66
103
117
219
107
152
Costs
-145
104
107
95
-454
154
Profit
211
-1
10
124
561
-2
Margin of profit
319.70
-0.97
8.55
56.62
524.30
-1.32
ROI
96.79
-0.31
3.00
25.36
82.02
-0.34

Balance Ligand Pharmaceuticals Inc

Balance
2015
2016
2017
2018
2019
2020
Equity
218
324
333
489
684
580
Debt
245
248
226
610
649
535
Total assets
463
572
559
1,099
1,333
1,115
Solvency
47.08
56.64
59.57
44.49
51.31
52.02
Cash
184
134
168
674
954
336
Cashflow
38
57
73
169
-26
44
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
0.16
0.23
0.32
0.28
-0.04
0.08

Details Ligand Pharmaceuticals Inc

Details
2016
2017
2018
2019
2020
Price
67.61
63.36
85.38
84.62
65.03
Eps
0.0
0.0
5.00
28.00
Price/earnings-ratio
0.0
0.0
17.08
3.02
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
15.50
15.75
23.55
40.66
36.07
Market to book
0.23
0.25
0.28
0.48
0.31
Cashflow per stock
2.73
3.45
8.14
-1.55
2.74
Stocks
21
21
21
17
16
Market Cap
1.413.68
1.339.98
1.772.96
1.423.56
1.900.98

Dividend Ligand Pharmaceuticals Inc


Price info Ligand Pharmaceuticals Inc

Date
Price
25 Jun 2025
118.22
20 Jun 2025
114.64
07 Jun 2025
105.99
03 Jun 2025
101.64
28 May 2025
101.64
27 May 2025
101.60
19 May 2025
104.54
09 May 2025
102.51
01 May 2025
109.86
29 Apr 2025
108.88
22 Apr 2025
104.81
09 Apr 2025
99.41
08 Apr 2025
99.41
03 Apr 2025
108.73
30 Mar 2025
107.62
27 Mar 2025
108.09
26 Mar 2025
109.69
20 Mar 2025
108.03
15 Mar 2025
106.19
12 Mar 2025
105.79
01 Mar 2025
122.23
25 Feb 2025
117.07
23 Feb 2025
120.67
18 Feb 2025
120.00
13 Feb 2025
111.39
12 Feb 2025
112.77
07 Feb 2025
117.84
05 Feb 2025
117.26
02 Feb 2025
116.55
21 Jan 2025
111.89